It should be noted that targeting CXCL12 and its receptor CXCR4 in mouse glioblastoma prevented HIF-1-mediated recruitment of pro-angiogenic TAM and TEM, reduced vasculogenesis and abrogated tumor growth after irradiation (Kioi et al., 2010). This evidence concerns the gene CXCL12 and neoplasm.